File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
  • Find via Find It@HKUL
Supplementary

Conference Paper: Mycophenolic acid reduces matrix synthesis in human mesangial cells stimulated with anti-DNA antibodies

TitleMycophenolic acid reduces matrix synthesis in human mesangial cells stimulated with anti-DNA antibodies
Authors
Issue Date2005
PublisherAmerican Society of Nephrology. The abstract suppl.'s website is located at https://www.asn-online.org/abstracts/
Citation
The 38th Annual Meeting and Scientific Exposition of the American Society of Nephrology (ASN Renal Week 2005), Pennsylvania, PA., 8-13 November 2005. In Journal of the American Society of Nephrology Abstract Supplement, 2005, v. 16, p. 420A, abstract no. F-PO392 How to Cite?
AbstractLupus nephritis is an important cause of acute or chronic renal failure. There is accumulating data to show that combined use of mycophenolate mofetil (MMF) and corticosteroid is an effective treatment for severe lupus nephritis. While the efficacy of MMF relates primarily to the inhibition of lymphocyte proliferation, there is preliminary evidence that it may have a direct effect on mesangial cells. We have thus investigated the actions of mycophenolic acid (MPA), the active metabolite of MMF, on human mesangial cells (HMC) stimulated with anti-DNA antibodies. Polyclonal anti-DNA antibodies were isolated from 12 patients with active diffuse proliferative lupus nephritis by affinity chromatography. Incubation of HMC with anti-DNA antibodies (10 μg/ml IgG concentration) for up to 96 h increased cell proliferation (p<0.05) and induced fibronectin, thrombospondin-1 and collagen type I synthesis in a time-dependent manner, compared with normal human IgG (p<0.05 for all). These changes were not observed with the non-anti-DNA immunoglobulin fractions of the corresponding sera, and were preceded by anti-DNA antibody induced TGF-β1 secretion and PKC-α activation. Concomitant addition of MPA (0-10 μM) and anti-DNA antibodies to HMC resulted in dose-dependent amelioration of the induced cell proliferation, which was significant after 48 h with an MPA concentration of ≥0.01 μM (p<0.05). MPA also significantly reduced fibronectin, thrombospondin-1 and collagen type I synthesis and deposition in the extracellular milieu, by abrogating TGF-β1 bioactivation and reducing activation of PKC-α. These effects of MPA on HMC in the presence of anti-DNA antibodies were reversible. We conclude that MPA can reduce anti-DNA antibody induced HMC proliferation and synthesis of matrix components, and these actions may contribute to the efficacy of MMF in the treatment of lupus nephritis.
Persistent Identifierhttp://hdl.handle.net/10722/102820
ISSN
2015 Impact Factor: 8.491
2015 SCImago Journal Rankings: 4.699

 

DC FieldValueLanguage
dc.contributor.authorChan, DTMen_HK
dc.contributor.authorTsang, RCWen_HK
dc.contributor.authorZhang, Qen_HK
dc.contributor.authorYung, SSYen_HK
dc.date.accessioned2010-09-25T20:46:09Z-
dc.date.available2010-09-25T20:46:09Z-
dc.date.issued2005en_HK
dc.identifier.citationThe 38th Annual Meeting and Scientific Exposition of the American Society of Nephrology (ASN Renal Week 2005), Pennsylvania, PA., 8-13 November 2005. In Journal of the American Society of Nephrology Abstract Supplement, 2005, v. 16, p. 420A, abstract no. F-PO392en_HK
dc.identifier.issn1046-6673en_HK
dc.identifier.urihttp://hdl.handle.net/10722/102820-
dc.description.abstractLupus nephritis is an important cause of acute or chronic renal failure. There is accumulating data to show that combined use of mycophenolate mofetil (MMF) and corticosteroid is an effective treatment for severe lupus nephritis. While the efficacy of MMF relates primarily to the inhibition of lymphocyte proliferation, there is preliminary evidence that it may have a direct effect on mesangial cells. We have thus investigated the actions of mycophenolic acid (MPA), the active metabolite of MMF, on human mesangial cells (HMC) stimulated with anti-DNA antibodies. Polyclonal anti-DNA antibodies were isolated from 12 patients with active diffuse proliferative lupus nephritis by affinity chromatography. Incubation of HMC with anti-DNA antibodies (10 μg/ml IgG concentration) for up to 96 h increased cell proliferation (p<0.05) and induced fibronectin, thrombospondin-1 and collagen type I synthesis in a time-dependent manner, compared with normal human IgG (p<0.05 for all). These changes were not observed with the non-anti-DNA immunoglobulin fractions of the corresponding sera, and were preceded by anti-DNA antibody induced TGF-β1 secretion and PKC-α activation. Concomitant addition of MPA (0-10 μM) and anti-DNA antibodies to HMC resulted in dose-dependent amelioration of the induced cell proliferation, which was significant after 48 h with an MPA concentration of ≥0.01 μM (p<0.05). MPA also significantly reduced fibronectin, thrombospondin-1 and collagen type I synthesis and deposition in the extracellular milieu, by abrogating TGF-β1 bioactivation and reducing activation of PKC-α. These effects of MPA on HMC in the presence of anti-DNA antibodies were reversible. We conclude that MPA can reduce anti-DNA antibody induced HMC proliferation and synthesis of matrix components, and these actions may contribute to the efficacy of MMF in the treatment of lupus nephritis.-
dc.languageengen_HK
dc.publisherAmerican Society of Nephrology. The abstract suppl.'s website is located at https://www.asn-online.org/abstracts/en_HK
dc.relation.ispartofJournal of the American Society of Nephrology Abstract Supplementen_HK
dc.rightsJournal of the American Society of Nephrology. Copyright © Lippincott Williams & Wilkins.en_HK
dc.titleMycophenolic acid reduces matrix synthesis in human mesangial cells stimulated with anti-DNA antibodiesen_HK
dc.typeConference_Paperen_HK
dc.identifier.openurlhttp://library.hku.hk:4550/resserv?sid=HKU:IR&issn=1046-6673&volume=16&spage=420A&epage=&date=2005&atitle=Mycophenolic+Acid+Reduces+Matrix+Synthesis+in+Human+Mesangial+Cells+Stimulated+with+Anti-DNA+Antibodiesen_HK
dc.identifier.emailChan, DTM: dtmchan@hku.hken_HK
dc.identifier.emailZhang, Q: zhjhr@hkucc.hku.hken_HK
dc.identifier.emailYung, SSY: ssyyung@hku.hken_HK
dc.identifier.authorityChan, DTM=rp00394en_HK
dc.identifier.authorityYung, SSY=rp00455en_HK
dc.identifier.hkuros112135en_HK
dc.identifier.volume16en_HK
dc.identifier.spage420A, abstract no. F-PO392en_HK
dc.identifier.epage420A, abstract no. F-PO392-
dc.publisher.placeUnited States-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats